| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 612,634 | 568,261 | 559,630 | 539,103 | | Cost of Revenue | 363,664 | 340,164 | 337,430 | 324,465 | | | Gross Profit | 248,970 | 228,097 | 222,200 | 214,638 | | | Operating Expenses | | Research Development | 52,272 | 48,761 | 50,189 | 52,344 | | Selling General and Administrative | 97,542 | 93,418 | 89,424 | 94,564 | | Non Recurring | 10,500 | 4,104 |
-
| 12,245 | | Others | 1,537 | 1,540 | 1,538 | 1,538 | | | | Total Operating Expenses | 161,851 | 147,823 |
-
| 160,691 | | | | Operating Income or Loss | 87,119 | 80,274 | 81,049 | 53,947 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (383) | (1,162) | 1,162 | 3,989 | | Earnings Before Interest And Taxes | 86,736 | 79,112 | 82,211 | 57,936 | | Interest Expense | 13,503 | 14,047 | 19,781 | 19,207 | | Income Before Tax | 73,233 | 65,065 | 62,430 | 38,729 | | Income Tax Expense | 20,434 | 16,983 | 15,233 | (10,240) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 52,799 | 48,082 | 47,197 | 48,969 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 52,799 | 48,082 | 47,197 | 48,969 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $52,799 | $48,082 | $47,197 | $48,969 |
|
0.29% Nasdaq 
Income Statement
